BlackRock’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.6M | Buy |
3,402,847
+529,888
| +18% | +$12.2M | ﹤0.01% | 2179 |
|
|
2025
Q1 | $77.6M | Buy |
2,872,959
+147,146
| +5% | +$3.97M | ﹤0.01% | 2126 |
|
|
2024
Q4 | $146M | Buy |
2,725,813
+303,177
| +13% | +$16.2M | ﹤0.01% | 1833 |
|
|
2024
Q3 | $110M | Buy |
2,422,636
+78,629
| +3% | +$3.57M | ﹤0.01% | 2009 |
|
|
2024
Q2 | $98.2M | Buy |
2,344,007
+650,016
| +38% | +$27.2M | ﹤0.01% | 2023 |
|
|
2024
Q1 | $63.8M | Sell |
1,693,991
-68,110
| -4% | -$2.56M | ﹤0.01% | 2274 |
|
|
2023
Q4 | $18.9M | Buy |
1,762,101
+122,522
| +7% | +$1.31M | ﹤0.01% | 2986 |
|
|
2023
Q3 | $16.5M | Buy |
1,639,579
+444,991
| +37% | +$4.49M | ﹤0.01% | 3006 |
|
|
2023
Q2 | $14.2M | Buy |
1,194,588
+59,943
| +5% | +$712K | ﹤0.01% | 3173 |
|
|
2023
Q1 | $13.7M | Buy |
1,134,645
+31,590
| +3% | +$382K | ﹤0.01% | 3094 |
|
|
2022
Q4 | $14.5M | Sell |
1,103,055
-147,293
| -12% | -$1.94M | ﹤0.01% | 3135 |
|
|
2022
Q3 | $16.9M | Buy |
1,250,348
+41,994
| +3% | +$569K | ﹤0.01% | 3073 |
|
|
2022
Q2 | $14.8M | Buy |
1,208,354
+46,633
| +4% | +$569K | ﹤0.01% | 3195 |
|
|
2022
Q1 | $16.7M | Buy |
1,161,721
+153,460
| +15% | +$2.2M | ﹤0.01% | 3217 |
|
|
2021
Q4 | $19.9M | Buy |
1,008,261
+206,483
| +26% | +$4.07M | ﹤0.01% | 3219 |
|
|
2021
Q3 | $17.3M | Buy |
801,778
+691,831
| +629% | +$15M | ﹤0.01% | 3329 |
|
|
2021
Q2 | $2.74M | Buy |
+109,947
| New | +$2.74M | ﹤0.01% | 4066 |
|